Health
Peptides For Post-Surgical Healing After Rhinoplasty
While rhinoplasty procedures vary in complexity and expected recovery times, everyone wants to heal faster and minimise downtime after the procedure. The success of the procedure to reduce pore size will not only depend on the skill of the surgeon but also the patient’s ability to heal properly.
In the past few years, a group of molecules, known as peptides, have increasingly gained significant attention in the medical field for their incredible potential in bolstering the healing process. Simply put, they are a group of naturally occurring or synthetic amino acids that have been shown to optimise healing and recovery times.
Let’s take a deeper look at peptides, how they work, their benefits, and how they can be used in post-surgical recovery after rhinoplasty.
How Peptides Enhance Healing
Before discussing the role of peptides in rhinoplasty healing, it’s vital to understand the healing process following a rhinoplasty procedure. Rhinoplasty typically involves the manipulation of nasal tissues, which includes cartilage, skin, and bone. Once the procedure is complete, the body will naturally undergo a sequence of healing events:
Inflammation – The body will first respond to the surgical trauma by triggering an inflammatory response. This is essential for clearing away any damaged tissue to start the healing process.
Proliferation – The body then starts to produce new blood vessels and initiates the formation of granulation tissue. During this stage, collagen production will increase to help rebuild the damaged tissue.
Remodeling – The final stage entails remodeling the newly formed tissue, including collagen. The scar tissue will gradually mature and gain strength.
The quality of healing will have a direct impact on the functional and aesthetic outcome of the rhinoplasty procedure. Improper or inadequate healing may lead to complications like poor nasal shape, scarring, and even breathing difficulties. This is where peptides come in.
Peptides mainly serve as signaling molecules, orchestrating a number of biological processes needed for healing and recovery. They do this by influencing various biological actors, including cytokines, growth factors, and immune cells. For instance, growth factors are needed for cell differentiation and cell proliferation, which are critical to tissue regeneration and wound healing.
Besides this, they influence cytokines, which play a critical role in regulating inflammation. Peptides such as TB-500 and BPC-157 can help control pain and inflammation associated with rhinoplasty by regulating the production of cytokines. They also influence immune system cells, which are responsible for not only protecting the body from infection but also facilitating tissue repair.
According to peptidesireland.com, some peptides have been shown to influence protein synthesis and the metabolism of fat, both of which have a vital impact on post-rhinoplasty recovery. By enhancing protein synthesis, peptides help with the repair of damaged tissues, and by optimising fat metabolism, they help with the overall healing and energy balance.
Benefits of Using Peptides for Healing
Using peptides for tissue repair has several potential benefits
Faster healing: Peptides can quicken the healing process, essentially shortening the recovery time from the rhinoplasty procedure. Faster healing means less discomfort, less downtime, and a faster return to normalcy.
Less pain and inflammation: Since peptides are naturally occurring in the body, they are usually well-tolerated with minimal side effects. While each peptide has its unique benefits, many will have anti-inflammatory properties, which can help alleviate pain associated with surgical procedures.
Antimicrobial properties: Peptides with antimicrobial properties, like LL-37, can help lower the risk of postoperative infections, which is a common concern following surgery.
Improved Angiogenesis: Peptides such as fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) help promote the formation of new blood vessels. They can help improve blood flow to the site of the wound, making sure there’s enough supply of oxygen and nutrients, which is vital for tissue healing.
Clinical Applications of Peptides in Rhinoplasty Healing
Although research is still ongoing when it comes to the application of peptides to heal rhinoplasty surgery, there are a few promising developments:
Topical peptide formulas: Topical peptide formulations may be used on the incision site to help stimulate the production of collagen and reduce scarring. The formulations are usually applied during the postoperative care period.
Injectable peptides: Some peptides are administered via injections to help target specific areas of the nose that might require additional healing support. This approach will essentially allow for more precise and tailored treatment.
Oral supplements: For some cases, oral supplements that contain peptides may be recommended to help promote overall healing from within.
Risks and Challenges of Using Peptides
While peptides offer great promise in enhancing rhinoplasty healing, there are several challenges to address. For starters, the efficacy and safety of certain peptides for postoperative care still need further investigation, and patient-specific elements should be considered in treatment plans.
As for the potential side effects, some patients may experience nausea, headache, or allergic reactions following peptide administration. These side effects will vary greatly from patient to patient and will be dependent on several factors, including the kind of peptide used, the amount of dose administered, and the overall health of the patient.
It’s also worth noting that while peptides are legal in many jurisdictions, some are considered performance-enhancement substances, and are therefore prohibited in certain sports. The potential misuse of peptides in industries such as bodybuilding and athletics also raises safety and ethical concerns.
Final Thoughts
The use of peptides to help with healing after rhinoplasty presents an exciting frontier in cosmetic surgery. By enhancing quality healing, peptides have the potential to lead to better functional and aesthetic outcomes.
Nonetheless, it’s still important to note that the field is still evolving, and further clinical research is needed to establish the safety and efficacy of certain peptide treatments.
By Modupe Gbadeyanka
The new one-hour authorisation response time ultimatum policy introduced by the National Health Insurance Authority (NHIA) has received the full backing of SUNU Health Nigeria Limited.
This policy was introduced by the agency to ensure enrollees get prompt approval codes to access care.
Healthcare service providers have been urged to report any Health Maintenance Organisation (HMO) that violates this initiative through an email, with the HMO in copy and a timestamp attached as evidence of the request. They may proceed to offer services to enrollees thereafter.
Speaking at the company’s second-quarter Providers’ Forum for the Lagos-Ogun region in Lagos recently, the chief executive of SUNU Health, Dr Moyosore Olomola, expressed optimism that this policy would improve healthcare delivery in the country, especially for enrollees, who crave quality service.
At the event themed Improving Quality and Access to Care Through Stronger Provider Network, and held at the Nigerian Institute of Medical Research (NIMR) in Yaba, Lagos, Mr Olomola reaffirmed the HMO’s commitment to operating within legal and operational frameworks to guarantee adequate care for enrollees.
“Access to care and quality of care remain key priorities in our healthcare systems. We know quite well that deliberate collaboration, strategic partnerships, and a shared commitment to excellence are required to achieve these priorities.
“A strong provider network is doubtless the backbone of any effective healthcare system. It ensures that our mutual enrollees receive the right care, at the right time, in the right place, and at the right price,” Mr Olomola, represented at the programme by the organisation’s Chief Operating Officer (COO), Dr Faith Nwachi, stated.
He further assured that SUNU Health would strictly adhere to the one-hour authorisation limit, stressing that this aligns seamlessly with one of the organisation’s core values—promptness and its corporate slogan, Humanity is the centre of our initiatives.
In a bid to further improve access and quality of care, SUNU Health also demonstrated its new operational software and Mobile app, aptly named SUNU Legacy.
Also speaking at the event, the NHIA Lagos State Coordinator (Ikeja), Dr Bethuel-Kasimu Abraham, noted that the forum’s expected outcome is to significantly reduce delays in accessing medical care.
Other key expectations include ensuring continuity of care, improving patient outcomes, and strengthening accountability among HMOs.
Addressing specific pain points faced by enrollees, the NHIA Ogun State Coordinator, Mr Dare Adefeso, acknowledged that the agency had received complaints regarding out-of-stock drugs and the discrimination of enrollees by certain providers.
He affirmed that the NHIA is actively addressing these issues, stressing that moving forward, every facility must ensure enrollees are properly catered to regardless of their status, provided they have an active health insurance plan.
Corroborating the long-standing legacy of SUNU Health, the Ogun State Director of the National Orientation Agency (NOA), Mrs Aishat Tiamiyu, shared that her agency is responsible for public information dissemination and has been enrolled with SUNU Health for over 25 years.
Commending the HMO’s stellar service over two decades, she called for the immediate enrollment of new NOA staff into the scheme.
The Providers’ Forum remains one of the strategic channels employed by SUNU Health to consistently engage healthcare providers, understand their operational challenges, introduce new software updates, and solidify partnerships aimed at fostering premium healthcare delivery across Nigeria.
By Aduragbemi Omiyale
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a sexual enhancement product known as WAP Sensual Enhancement Capsules.
In a statement on Monday, the Nigerian agency disclosed that the recall is due to “undeclared pharmaceutical ingredients” in the product, whose country of origin is unknown, but is marketed and distributed online in the US through eBay.
It was emphasised that the recall is being “voluntarily” made by the manufacturer, Best Supplements Best Prices Company.
The detection of the undeclared pharmaceutical ingredients was made by the US Food and Drug Administration (FDA).
Laboratory analysis by the US FDA revealed that the product contained undeclared sildenafil, tadalafil, and flibanserin, which were not mentioned on the product label. Such substances may include phosphodiesterase type-5 (PDE-5) inhibitors or related compounds commonly used for the treatment of erectile dysfunction, the statement by NAFDAC stated.
Sildenafil and tadalafil are ingredients in FDA-approved prescription drugs used to treat erectile dysfunction.
It was noted that these undeclared ingredients may interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.
Flibanserin is the active ingredient in an FDA-approved prescription drug used to treat low sexual desire in women. Flibanserin can cause drowsiness, sedation, dangerously low blood pressure, and fainting, especially when combined with alcohol.
Consumers have been encouraged to report compromised products (medicines or medical devices) to the nearest NAFDAC office, call 0800-162-3322, or send an email to sf******@********ov.ng.
By Modupe Gbadeyanka
Dr Obi Adigwe has been appointed as the pioneer National Coordinator of the National Health Technology and Data Analytics Office (NHTDAO).
The body was created by the Ministry of Health under the approval of President Bola Tinubu.
NHTDAO will be domiciled in the Office of the Coordinating Minister of Health and Social Welfare, a statement on Friday by the Special Adviser to the President on Information and Strategy, Mr Bayo Onanuga, stated.
The agency will serve as a meta-level national platform for coordinating the country’s digital-health agenda. It will reinforce, not replace, the existing statutory functions of relevant departments and agencies, it was emphasised.
The organisation will also harmonise and empower the public and private institutions across the health system, set the standards that connect them, and operationalise the National Digital Health Architecture, approved by the National Council on Health in November 2025.
It was stated that President Tinubu expects NHTDAO to accelerate Nigeria’s transition to a secure, interoperable and data-driven health system that improves outcomes for all citizens.
Mr Adigwe, as Director General of the National Institute for Pharmaceutical Research and Development, has leveraged science to catalyse interventions in artificial intelligence, translational research, and technology transfer.
He coordinated major projects, including the ¥300m Nanotechnology grant and the AFREXIMBank grant for Africa’s first API Training Facility. He led the roadmap development that underpinned an €18 million EU grant, the largest in Africa for the thematic area. During the last pandemic, Adigwe globally showcased African science by undertaking the world’s first analysis to debunk claims about the Covid Organics preparation.
The Office’s Steering Committee, which provides strategic direction and oversight, comprises:
- Professor Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare (Co-chair)
- Mr Olaniyi Yusuf, Chairman of the Nigerian Economic Summit Group (Co-chair)
- Dr Iziaq Adekunle Salako, Minister of State for Health and Social Welfare (Alternate Co-chair)
- Ms Kachollom Daju, Permanent Secretary, Federal Ministry of Health and Social Welfare
- Mr Idris Alubankudi Saliu, Special Adviser to the President on Technology and Digital Economy
- Dr Muntaqa Umar-Sadiq, National Coordinator, SWAp Coordination Office
- Dr Abdu Mukhtar, National Coordinator, Presidential Initiative to Unlock Healthcare Value Chain
- Dr Muyi Aina, Executive Director, National Primary Health Care Development Agency
- Dr Kelechi Ohiri, Director General, National Health Insurance Authority
- Director, Health Planning, Research and Statistics, Ministry of Health and Social Welfare
- National Information Technology Development Agency Representative
- Six representatives of the State Commissioners of Health, one from each of the six geopolitical zones
- Pharm Hamza Buhari, Stakeholder representing Industry and Community.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz4 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn